Aethlon Medical Inc Price/Book
Cos'è Price/Book di Aethlon Medical Inc?
Price/Book di Aethlon Medical Inc è 0.71
Qual è la definizione di Price/Book?
Il rapporto Price to book rappresenta il rapporto tra il valore delle azioni di una società e il valore contabile per azione.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Price/Book di aziende nel Industrials settore su NASDAQ rispetto a Aethlon Medical Inc
Cosa fa Aethlon Medical Inc?
the aethlon medical (nasdaq:aemd) mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. our aethlon adapt™ platform provides the technology foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. the aethlon adapt™ product pipeline includes the hemopurifier®, a first-in-class medical device with broad-spectrum capabilities against exosomes that contribute to the progression of cancer and infectious viral pathogens such as hiv and hepatitis c.
Aziende con price/book simili a Aethlon Medical Inc
- Vendetta Mining ha Price/Book di 0.71
- Bayer AG ha Price/Book di 0.71
- Hopefluent ha Price/Book di 0.71
- Orange SA ha Price/Book di 0.71
- MEP Infrastructure Developers ha Price/Book di 0.71
- Diana Shipping Inc ha Price/Book di 0.71
- Aethlon Medical Inc ha Price/Book di 0.71
- Amplify ha Price/Book di 0.71
- Kingfisher plc ha Price/Book di 0.71
- Great China Properties ha Price/Book di 0.71
- Aurion Resources ha Price/Book di 0.71
- Franklin Duration Income Trust ha Price/Book di 0.71
- Autolite (India) ha Price/Book di 0.71